RIGH. “This will benefit current shareholders by the acquisition and development of both medical technology and data technology through parallel growth trajectories. Genius Biotech Corporation is in a position to benefit greatly from the continued legalization of medical marijuana, while our crossover products benefit synergistically from emerging recreational marijuana markets.”
http://www.businesswire.com/news/home/2014071...Cv0mxYldpd

http://investorshangout.com/post/postreplies?id=2029981